Cargando…

Association of 17q22 Amplicon Via Cell-Free DNA With Platinum Chemotherapy Response in Metastatic Triple-Negative Breast Cancer

PURPOSE: To determine whether specific somatic copy-number alterations detectable in circulating tumor DNA (ctDNA) from patients with metastatic triple-negative breast cancer (mTNBC) are associated with sensitivity to platinum chemotherapy. MATERIALS AND METHODS: In this secondary analysis of a larg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collier, Katharine A., Asad, Sarah, Tallman, David, Jenison, Janet, Rajkovic, Andrei, Mardis, Elaine R., Parsons, Heather A., Tolaney, Sara M., Winer, Eric P., Lin, Nancy U., Ha, Gavin, Adalsteinsson, Viktor A., Stover, Daniel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2021
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624042/ https://www.ncbi.nlm.nih.gov/pubmed/34849445 http://dx.doi.org/10.1200/PO.21.00104

Ejemplares similares

Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer
por: Weber, Zachary T., et al.
Publicado: (2021)

PDJ amplicon in triple negative breast cancer
por: Roesler, Alexander S., et al.
Publicado: (2023)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
por: Doebley, Anna-Lisa, et al.
Publicado: (2022)

Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
por: Doebley, Anna-Lisa, et al.
Publicado: (2023)

Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
por: Gersten, Benjamin K., et al.
Publicado: (2020)

Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.
por: Forus, A., et al.
Publicado: (1998)

Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis
por: Lin, Canling, et al.
Publicado: (2022)

Platinum‐based chemotherapy for early triple‐negative breast cancer
por: Mason, Sofia RE, et al.
Publicado: (2023)

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy
por: Walsh, Elaine M., et al.
Publicado: (2018)

Hydrolysis of Methionine- and Histidine-Containing Peptides Promoted by Dinuclear Platinum(II) Complexes with Benzodiazines as Bridging Ligands: Influence of Ligand Structure on the Catalytic Ability of Platinum(II) Complexes
por: Rajković, Snežana, et al.
Publicado: (2018)

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
por: Turner, Nicholas, et al.
Publicado: (2010)

Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer
por: Chen, Yimeng, et al.
Publicado: (2023)

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer
por: Stover, Daniel G., et al.
Publicado: (2018)

Massively-parallel enrichment of minor alleles for mutational testing via low-depth duplex sequencing
por: Gydush, Gregory, et al.
Publicado: (2022)

Platinum-based chemotherapy in triple-negative breast cancer: A meta-analysis
por: LIU, MIAO, et al.
Publicado: (2013)

(5,5′-Dimethyl-2,2′-bipyridine)iodidotrimethylplatinum(IV)
por: Lundvall, Fredrik, et al.
Publicado: (2011)

Genomic features of rapid versus late relapse in triple negative breast cancer
por: Zhang, Yiqing, et al.
Publicado: (2021)

Herpes Virus Amplicon Vectors
por: de Silva, Suresh, et al.
Publicado: (2009)

Long-read amplicon denoising
por: Kumar, Venkatesh, et al.
Publicado: (2019)

Bromido(2,2′:6′,2′′-terpyridine)platinum(II) dibromidoaurate(I) dimethyl sulfoxide solvate
por: Kahn, Michael I., et al.
Publicado: (2009)

Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy
por: Zhang, Jian, et al.
Publicado: (2015)

Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing
por: Prodan, Andrei, et al.
Publicado: (2020)

SESAME (SEquence Sorter & AMplicon Explorer): genotyping based on high-throughput multiplex amplicon sequencing
por: Meglécz, Emese, et al.
Publicado: (2011)

Amplicon –Based Metagenomic Analysis of Mixed Fungal Samples Using Proton Release Amplicon Sequencing
por: Tonge, Daniel P., et al.
Publicado: (2014)

Technological considerations for genome-guided diagnosis and management of cancer
por: Lennon, Niall J., et al.
Publicado: (2016)

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects
por: Zhou, Zhaowei, et al.
Publicado: (2019)

1k-RiCA (1K-Rice Custom Amplicon) a novel genotyping amplicon-based SNP assay for genetics and breeding applications in rice
por: Arbelaez, Juan David, et al.
Publicado: (2019)

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
por: Parsons, Heather A., et al.
Publicado: (2023)

Correction: Amplicon–Based Metagenomic Analysis of Mixed Fungal Samples Using Proton Release Amplicon Sequencing
Publicado: (2014)

AmpliconDuo: A Split-Sample Filtering Protocol for High-Throughput Amplicon Sequencing of Microbial Communities
por: Lange, Anja, et al.
Publicado: (2015)

Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness
por: Metzger-Filho, Otto, et al.
Publicado: (2021)

Immunotherapy for early triple negative breast cancer: research agenda for the next decade
por: Tarantino, Paolo, et al.
Publicado: (2022)

Chiral discrimination in platinum anticancer drugs.
por: Benedetti, Michele, et al.
Publicado: (2002)

Cancer Genomics
por: Mardis, Elaine
Publicado: (2015)

A Sequel to Sanger: amplicon sequencing that scales
por: Hebert, Paul D. N., et al.
Publicado: (2018)

CDK4/6 inhibition in breast cancer: current practice and future directions
por: Pernas, Sonia, et al.
Publicado: (2018)

Effectiveness of Platinum-Based Treatment for Triple Negative Metastatic Breast Cancer: a Meta-Analysis
por: Kaya, Vildan, et al.
Publicado: (2018)

Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
por: Li, Junjie, et al.
Publicado: (2022)

Monofunctional and Interstrand DNA Adducts of Platinum(II) Complexes
por: Brabec, Viktor, et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_ahivjmg872svum80cum1m5h75b